{
    "title": "Teva Pharm expects U.S. opioid case settlements to cost $2.6 bln",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10778321/Teva-Pharm-Q1-profit-cuts-2022-revenue-outlook.html",
    "date": "2022-05-03",
    "keywords": [
        "settlement",
        "revenue",
        "year",
        "share",
        "cash",
        "drug",
        "schultz",
        "teva",
        "treatment",
        "medicine",
        "state",
        "florida",
        "island",
        "america",
        "competition",
        "ajovy",
        "debt",
        "reporting",
        "scheer",
        "jerusalem",
        "drugmaker",
        "provision",
        "litigation",
        "quarter",
        "result",
        "assessment",
        "effect",
        "outcome",
        "k\u00e5re",
        "conference",
        "call",
        "profit",
        "march",
        "rhode",
        "trial",
        "virginia",
        "month",
        "francisco",
        "july",
        "time",
        "schedule",
        "end",
        "substance",
        "abuse",
        "help",
        "worth",
        "suboxone",
        "tevas",
        "preference",
        "point",
        "distribution",
        "value",
        "januarymarch",
        "period",
        "sclerosis",
        "copaxone",
        "refinitiv",
        "currency",
        "estimate",
        "projection",
        "versus",
        "market",
        "disease",
        "europe",
        "company",
        "midday",
        "knauth",
        "louise",
        "potter",
        "david",
        "gregorio"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}